Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Comment by Stocktreeon Oct 03, 2016 3:08pm

123 Views

Post# 25303473

RE:RE:Numbers impossible, anomaly/cheat... correct me maybe

Yes, greatest placebo of all time.

Is the 62% representative of other MODS 9 high endotoxin level patients?

Is the EAA test effective at all? The patients were screened with the EAA. Did patients with a lesser endotoxin level fall into the placebo group?

Bullboard Posts

NervGen Pharma: Proof that NVG-291 works?